Galderma Investigational Site 8893 is a clinical research site located in Birmingham, Alabama, United States 35244.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Galderma Investigational Site 8893 has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Moderate-to-Severe Atopic Dermatitis, Prurigo Nodularis, Atopic Dermatitis.
Sponsors: Galderma R&D.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Alabama · View every site in Birmingham
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Galderma Investigational Site 8893 has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Galderma Investigational Site 8893 has 4 clinical trials on record, with 3 currently active. Their work covers Moderate-to-Severe Atopic Dermatitis, Prurigo Nodularis, Atopic Dermatitis.
Galderma Investigational Site 8893 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.